The Weekly Roundup: March 6-10

POLL: What is a Precursor to Squamous Cell Carcinoma?

Click here to answer this week's poll.

Recommendations for Treating Oily and Acne-Prone Skin

The management of oily and acne-prone skin remains a challenge for both patients and dermatology professionals.

The Mainstream Patient: March 6

This week's edition of the Mainstream Patient features stories about understanding scalp psoriasis, biotin shampoos for healthier hair, azelaic acid for acne and rosacea treatment, and more.

Hidradenitis Suppurativa Linked to Atopic Diseases

Following a systematic review and observational study meta-analysis, researchers have uncovered an association between hidradenitis suppurativa and several atopic diseases.

New Positive Results of Oral IL-23 Receptor Antagonist for Psoriasis

JNJ-2113 met primary endpoints in the FRONTIER 1 clinical trial.

Topical Clascoterone Cream Safe, Efficacious in Facial Acne Vulgaris Treatment

Researchers conducted a pooled data analysis using previous study data to determine the cream’s efficacy in patients ages 12 and up.

FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

Novan’s expected PDUFA date is January 5, 2024.

Share With Us: What Does It Mean to Be a Woman in Dermatology?

Interested in sharing your perspectives as a woman in dermatology? Contact us.

Scientists Say They’ve Developed a Safer Sunscreen

A prototype for a coral-reef-friendly sunscreen is more effective at preventing sunburn in mice than existing sunscreens.

FDA Reviewing Dupilumab for Chronic Spontaneous Urticaria

The treatment for adults and adolescents with the type 2 inflammatory skin condition has been accepted for FDA review.

Spotlighting Women In Dermatology

This International Women's Day, the Dermatology Times® team is taking the time to spotlight women in the dermatology field.

Pointers With Portela: Skin Care for Sensitive Skin

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the best skin care brands for sensitive skin in 2023.

Incyte Will Present Multiple Dermatology Abstracts at AAD 2023

Updates from Incyte’s dermatology portfolio include late-breaking data on ruxolitinib cream and povorcitinib for vitiligo.

CDC Issues Measles Alert After 200,000 Exposed in Kentucky

The alert advises attendees that are not fully vaccinated to quarantine and monitor symptoms for 21 days.

Hidradenitis Suppurativa Factors Affecting Patient Quality of Life

Researchers say disease severity, site, and comorbidities may lower a patient’s quality of life as they navigate hidradenitis suppurativa.

Allergan Aesthetics Partners with IFundWomen to Empower Entrepreneurship

The AbbVie company announced their partnership with the grant program to encourage women to own their own businesses.

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

In this episode, Mona Shahriari, MD, discusses what dermatologists and patients with atopic dermatitis can expect as we transition from winter to spring, as well as new and emerging treatments and technologies for managing atopic dermatitis that she’s looking ahead to as the year progresses.

FDA Clears PicoWay Laser for Melasma, Lentigines, and More

The picosecond system has previously been approved for treating acne scarring, pigmented lesions, tattoo removal, and wrinkles.

Frontline Forum Part 1: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

In part 1 of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.

Sarecycline’s Lipophilicity May Explain Lower Rates of Adverse Events

Study investigators evaluated the blood-brain barrier penetrance and lipophilicity of the narrow-spectrum, third-generation tetracycline-class oral antibiotic used for acne treatment.

Alzheimer’s Disease Drug May Improve Trichotillomania

The study suggests memantine could be considered a first-line treatment equal to behavioral therapy in the treatment process.

TMB-001 for Congenital Ichthyosis Subtypes Tested by Dermatologists

Yale School of Medicine is a testing site for a potential new congenital ichthyosis treatment.

Considering and Improving Patient Quality of Life in Dermatologic Conditions

Many dermatologic conditions have demonstrated proven impacts on patients and their quality of life.

Strengthen Your Expertise and Your Practice One Conference at a Time

Conferences provide valuable information and resources to help you grow in the dermatology space.

Anxiety and Depression Prevalent in Patients With Alopecia

Following a meta-data analysis, researchers say the prevalence of these psychological conditions in patients with alopecia areata is greater than that of the standard population.